Vitamin and supplement manufacturer HINNAO has released a new glutathione liquid supplement.
According to the company, the supplement is taken orally and the HINNAO high-stability liposomal technology enables glutathione to be absorbed through the mucous membrane into the bloodstream, bypassing the gastrointestinal tract.
Sophie Reed, co-founder at HINNAO, said, “We are excited to launch our HINNAO high stability liposomal glutathione into the UK and Europe, offering practitioners the opportunity to treat their patients with glutathione. Since 2013, we have been developing our technology with the main focus being clinically proven bioavailability.”
